NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Zhejiang Starry Pharmaceutical Co. Ltd (SHG: 603520)
603520 Technical Analysis
4
As on 19th Aug 2025 603520 STOCK Price closed @ 12.16 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.93 & Buy for SHORT-TERM with Stoploss of 11.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
603520STOCK Price
Open | 11.05 | Change | Price | % |
High | 12.16 | 1 Day | 1.11 | 10.05 |
Low | 11.05 | 1 Week | 1.22 | 11.15 |
Close | 12.16 | 1 Month | 2.10 | 20.87 |
Volume | 22823891 | 1 Year | 3.56 | 41.40 |
52 Week High 13.19 | 52 Week Low 7.39 |
SHG China Most Active Stocks
600010 | 2.66 | -0.75% |
601162 | 5.63 | -2.93% |
601929 | 3.99 | -7.42% |
600705 | 3.47 | 0.29% |
600811 | 0.36 | -2.70% |
600208 | 5.54 | 3.75% |
600795 | 4.77 | 5.76% |
601989 | 5.10 | 1.80% |
601288 | 7.02 | 1.30% |
600601 | 7.63 | 2.69% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
603520 Daily Charts |
603520 Intraday Charts |
Whats New @ Bazaartrend |
603520 Free Analysis |
|
603520 Important Levels Intraday
RESISTANCE | 14.30 |
RESISTANCE | 13.61 |
RESISTANCE | 13.19 |
RESISTANCE | 12.76 |
SUPPORT | 11.56 |
SUPPORT | 11.13 |
SUPPORT | 10.71 |
SUPPORT | 10.02 |
603520 Forecast August 2025
4th UP Forecast | 18.35 |
3rd UP Forecast | 16.36 |
2nd UP Forecast | 15.14 |
1st UP Forecast | 13.91 |
1st DOWN Forecast | 10.41 |
2nd DOWN Forecast | 9.18 |
3rd DOWN Forecast | 7.96 |
4th DOWN Forecast | 5.97 |
603520 Weekly Forecast
4th UP Forecast | 18.33 |
3rd UP Forecast | 16.35 |
2nd UP Forecast | 15.13 |
1st UP Forecast | 13.90 |
1st DOWN Forecast | 10.42 |
2nd DOWN Forecast | 9.19 |
3rd DOWN Forecast | 7.97 |
4th DOWN Forecast | 5.99 |
603520 Forecast2025
4th UP Forecast | 24.3 |
3rd UP Forecast | 20.41 |
2nd UP Forecast | 18 |
1st UP Forecast | 15.59 |
1st DOWN Forecast | 8.73 |
2nd DOWN Forecast | 6.32 |
3rd DOWN Forecast | 3.91 |
4th DOWN Forecast | 0.02 |
Zhejiang Starry Pharmaceutical Co. Ltd ( SHG China Symbol : 603520 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
603520 Other Details
Segment | EQ | |
Market Capital | 11687597056.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
603520 Address
![]() |
603520 Latest News
603520 Business Profile
Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China. Address: Xianju modern industrial cluster, Xianju, China, 317300
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service